SRRTB_XENLA
ID SRRTB_XENLA Reviewed; 844 AA.
AC Q6INH5; Q8AVP5;
DT 22-SEP-2009, integrated into UniProtKB/Swiss-Prot.
DT 05-JUL-2004, sequence version 1.
DT 03-AUG-2022, entry version 76.
DE RecName: Full=Serrate RNA effector molecule homolog B;
DE AltName: Full=Arsenite-resistance protein 2-B;
GN Name=srrt-b; Synonyms=ars2-b;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Embryo;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Acts as a mediator between the cap-binding complex (CBC) and
CC the primary microRNAs (miRNAs) processing machinery during cell
CC proliferation. Contributes to the stability and delivery of capped
CC primary miRNA transcripts to the primary miRNA processing complex,
CC thereby playing a role in RNA-mediated gene silencing (RNAi) by miRNAs
CC (By similarity). {ECO:0000250}.
CC -!- SUBUNIT: Interacts ncbp1/cbp80. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}. Cytoplasm
CC {ECO:0000250}. Note=Predominantly nuclear. Shuttles between the nucleus
CC and the cytoplasm (By similarity). {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the ARS2 family. {ECO:0000305}.
CC -!- SEQUENCE CAUTION:
CC Sequence=AAH41542.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC041542; AAH41542.1; ALT_SEQ; mRNA.
DR EMBL; BC072306; AAH72306.1; -; mRNA.
DR RefSeq; NP_001082532.1; NM_001089063.1.
DR AlphaFoldDB; Q6INH5; -.
DR SMR; Q6INH5; -.
DR PRIDE; Q6INH5; -.
DR DNASU; 398542; -.
DR GeneID; 398542; -.
DR KEGG; xla:398542; -.
DR CTD; 398542; -.
DR Xenbase; XB-GENE-5825723; srrt.L.
DR OrthoDB; 525905at2759; -.
DR Proteomes; UP000186698; Chromosome 3L.
DR Bgee; 398542; Expressed in neurula embryo and 19 other tissues.
DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR GO; GO:0006397; P:mRNA processing; IEA:InterPro.
DR GO; GO:0031053; P:primary miRNA processing; ISS:UniProtKB.
DR Gene3D; 3.30.70.330; -; 1.
DR InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR InterPro; IPR035979; RBD_domain_sf.
DR InterPro; IPR039727; SE/Ars2.
DR InterPro; IPR007042; SERRATE/Ars2_C.
DR InterPro; IPR021933; SERRATE/Ars2_N.
DR PANTHER; PTHR13165; PTHR13165; 1.
DR Pfam; PF04959; ARS2; 1.
DR Pfam; PF12066; SERRATE_Ars2_N; 1.
DR SUPFAM; SSF54928; SSF54928; 1.
PE 2: Evidence at transcript level;
KW Cytoplasm; Nucleus; Reference proteome; RNA-mediated gene silencing.
FT CHAIN 1..844
FT /note="Serrate RNA effector molecule homolog B"
FT /id="PRO_0000385213"
FT REGION 1..90
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 277..401
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 555..575
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 794..825
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 277..352
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 374..400
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 844 AA; 97871 MW; 062C2E44FC487843 CRC64;
MADSDDEHDR RRRDKFRRER SDYDRSRERE ERRRDDWSDR EWDRGRERRS RGEYRDYESR
SRRDRFSPQR HDISPPQKRM RRDWDDHGSD PYHSGYEMPY SSSAGPAYGP PQPWGHPEMH
VMQHHGIPIQ ARLGNLHDVD LGTPAPTMKT FKEFLLSLED SVDETEAVKR YNDYKIDFRR
QQMQEFFLAH KDEEWFRSKY HPDEVGKHKQ ESRASLHNRL NAFMFLMENS WLNEVQLDIA
QSTAIIKVLD AAVIKMEGGT EIDLKILDEE EEEAKREAAK KEEARVTETE KVITEEKEAP
AKPEKDKEPE SEEKPVKPEE EEEKKVEKEE PERETRKPGT RKRKRSGDSD DGSDSESDTE
TASPKPETPN QNGCEDTPKK EEETEKPKEK PKEDTVKPRP LHKTCSIFMR NIPPNISKAE
ITALCKRYPG FMRVALSEPQ PERRFLRKAY VTFDRSVNIK EICWSVQNIR LRECELSPGV
NRDLTYRVRN INGITLHRPI VRNDIKLAAR LIHALDERAQ LWEGEQGDQV VSAQNPILKN
ITDYLIDEVN AEEEELLSSA GRTPETEAPK EGNPTEITVE RDEKLIKVLD KLLFYLRIVH
SVDYYNTCEY PNEDEMPTRC GMMHVRGPLP PNRVSHGEVT EWQKTIEEKL APLFAVRETL
SEDEAMKMGK KDPEQEAEKF VTANTQELGK EKWLCPLSGK KFKGPEFVRK HIFNKHAEKI
EEVKKEVEFF NNYLTDSKRP ALPEVKPLQP PGGAAGQALA AGLLYPPQGP QALLPYGQPR
PPVLGYGGAP QFPPNPYGAG RGNYDSFRGQ GMYPGKPRNR MMRGDPRSII EYRDLDAPDD
VDFF